WELL Price To Sales Ratio vs Ptb Ratio Analysis

WELL Stock  CAD 5.86  0.31  5.59%   
WELL Health financial indicator trend analysis is more than just analyzing WELL Health Technologies current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether WELL Health Technologies is a good investment. Please check the relationship between WELL Health Price To Sales Ratio and its Ptb Ratio accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WELL Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Price To Sales Ratio vs Ptb Ratio

Price To Sales Ratio vs Ptb Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of WELL Health Technologies Price To Sales Ratio account and Ptb Ratio. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between WELL Health's Price To Sales Ratio and Ptb Ratio is -0.02. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ptb Ratio in the same time period over historical financial statements of WELL Health Technologies, assuming nothing else is changed. The correlation between historical values of WELL Health's Price To Sales Ratio and Ptb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of WELL Health Technologies are associated (or correlated) with its Ptb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ptb Ratio has no effect on the direction of Price To Sales Ratio i.e., WELL Health's Price To Sales Ratio and Ptb Ratio go up and down completely randomly.

Correlation Coefficient

-0.02
Relationship DirectionNegative 
Relationship StrengthInsignificant

Price To Sales Ratio

Price to Sales Ratio is figured by comparing WELL Health Technologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on WELL Health sales, a figure that is much harder to manipulate than other WELL Health Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.
Most indicators from WELL Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into WELL Health Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WELL Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, WELL Health's Selling General Administrative is very stable compared to the past year. As of the 2nd of December 2024, Tax Provision is likely to grow to about 3 M, while Discontinued Operations is likely to drop (257.1 K).
 2021 2022 2023 2024 (projected)
Gross Profit153.7M303.3M311.5M327.1M
Total Revenue302.3M569.1M776.1M814.9M

WELL Health fundamental ratios Correlations

0.941.01.00.98-0.980.620.620.751.01.00.970.990.951.00.991.00.930.981.00.890.991.00.780.990.99
0.940.940.960.9-0.910.560.560.810.950.920.940.970.920.950.920.940.920.860.940.980.910.960.80.90.88
1.00.940.990.98-0.980.60.60.771.01.00.960.990.940.991.01.00.920.981.00.881.01.00.770.990.99
1.00.960.990.96-0.980.650.650.760.990.990.980.990.961.00.980.990.940.960.990.910.980.990.820.970.98
0.980.90.980.96-0.940.460.460.780.980.990.90.980.880.960.990.980.860.970.980.870.990.980.650.990.97
-0.98-0.91-0.98-0.98-0.94-0.7-0.7-0.69-0.98-0.98-0.96-0.96-0.97-0.98-0.97-0.98-0.95-0.98-0.98-0.85-0.98-0.97-0.82-0.95-0.98
0.620.560.60.650.46-0.71.00.290.580.580.760.540.740.660.560.620.720.630.60.420.570.560.910.540.66
0.620.560.60.650.46-0.71.00.290.580.580.760.540.740.660.560.620.720.630.60.420.570.560.910.540.66
0.750.810.770.760.78-0.690.290.290.760.750.760.810.730.760.770.790.70.650.750.750.740.80.460.80.69
1.00.951.00.990.98-0.980.580.580.760.990.961.00.940.990.990.990.920.971.00.910.991.00.770.980.98
1.00.921.00.990.99-0.980.580.580.750.990.950.980.930.991.00.990.90.991.00.861.00.990.740.990.99
0.970.940.960.980.9-0.960.760.760.760.960.950.950.970.980.940.970.950.930.960.860.940.960.880.930.95
0.990.970.990.990.98-0.960.540.540.811.00.980.950.930.990.990.990.920.950.990.940.981.00.750.980.96
0.950.920.940.960.88-0.970.740.740.730.940.930.970.930.960.930.950.980.920.940.860.920.940.850.90.93
1.00.950.991.00.96-0.980.660.660.760.990.990.980.990.960.980.990.940.970.990.890.980.990.820.970.98
0.990.921.00.980.99-0.970.560.560.770.991.00.940.990.930.980.990.90.981.00.871.00.990.721.00.99
1.00.941.00.990.98-0.980.620.620.790.990.990.970.990.950.990.990.930.970.990.880.990.990.770.990.98
0.930.920.920.940.86-0.950.720.720.70.920.90.950.920.980.940.90.930.890.920.870.890.920.870.870.9
0.980.860.980.960.97-0.980.630.630.650.970.990.930.950.920.970.980.970.890.980.80.990.960.750.971.0
1.00.941.00.990.98-0.980.60.60.751.01.00.960.990.940.991.00.990.920.980.891.01.00.770.990.99
0.890.980.880.910.87-0.850.420.420.750.910.860.860.940.860.890.870.880.870.80.890.860.920.720.840.82
0.990.911.00.980.99-0.980.570.570.740.991.00.940.980.920.981.00.990.890.991.00.860.990.730.990.99
1.00.961.00.990.98-0.970.560.560.81.00.990.961.00.940.990.990.990.920.961.00.920.990.750.980.97
0.780.80.770.820.65-0.820.910.910.460.770.740.880.750.850.820.720.770.870.750.770.720.730.750.690.78
0.990.90.990.970.99-0.950.540.540.80.980.990.930.980.90.971.00.990.870.970.990.840.990.980.690.98
0.990.880.990.980.97-0.980.660.660.690.980.990.950.960.930.980.990.980.91.00.990.820.990.970.780.98
Click cells to compare fundamentals

WELL Health Account Relationship Matchups

WELL Health fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets58.5M262.7M1.3B1.3B1.4B1.5B
Other Current Liab1.0M10.1M12.7M35.7M37.5M39.3M
Total Current Liabilities8.4M22.6M137.3M136.5M153.0M160.6M
Total Stockholder Equity32.0M217.4M618.2M732.3M767.7M806.0M
Net Debt3.5M(63.3M)340.0M309.5M382.9M402.0M
Retained Earnings(17.1M)(20.8M)(64.6M)(63.7M)(63.6M)(60.4M)
Cash15.6M86.9M61.9M48.9M43.4M22.1M
Cash And Short Term Investments15.6M86.9M61.9M48.9M43.4M22.1M
Liabilities And Stockholders Equity58.5M262.7M1.3B1.3B1.4B1.5B
Other Current Assets704.7K1.5M3.7M520K21.6M22.7M
Other Stockholder Equity3.7M6.4M44.0M51.8M54.0M56.8M
Total Liab26.5M43.8M554.4M503.8M563.2M591.3M
Total Current Assets18.9M103.4M142.9M150.9M176.4M185.2M
Net Receivables2.5M8.9M71.8M95.8M110.2M115.7M
Common Stock Shares Outstanding96.9M133.9M190.9M220.7M236.5M248.4M
Common Stock45.4M231.9M633.5M705.2M751.6M789.1M
Property Plant And Equipment Net12.5M20.9M88.6M82.5M102.5M107.7M
Accounts Payable5.4M6.3M63.0M50.7M47.9M50.3M
Non Current Assets Total39.6M159.4M1.1B1.2B1.2B1.3B
Non Currrent Assets Other221.8K246.5K644K5.1M4.4M4.6M
Non Current Liabilities Total18.1M21.1M417.1M367.3M410.2M430.7M
Capital Surpluse3.7M6.4M44.0M51.8M59.5M62.5M
Inventory61.5K1.3M793K1.4M1.2M595.1K
Short Term Debt1.5M3.4M57.4M43.3M61.0M64.0M
Good Will13.6M110.1M611.7M499.3M508.1M533.5M
Long Term Debt Total17.7M20.2M344.6M315.2M362.4M380.6M
Cash And Equivalents15.6M86.9M61.9M48.9M56.2M33.9M
Net Tangible Assets7.1M86.0M(399.0M)(338.2M)(304.4M)(289.2M)
Long Term Debt4.7M947.9K290.6M263M298.9M313.9M
Other Liab478.5K920.4K72.5M52.1M59.9M62.9M
Other Assets2.0M1.8M2.9M3.2M3.7M2.2M
Property Plant Equipment12.5M20.9M88.6M82.5M94.9M99.7M

Other Information on Investing in WELL Stock

Balance Sheet is a snapshot of the financial position of WELL Health Technologies at a specified time, usually calculated after every quarter, six months, or one year. WELL Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of WELL Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which WELL currently owns. An asset can also be divided into two categories, current and non-current.